Find policies, billing codes, payers, states, and providers
CPT 78610: Cerebral Perfusion Study, Nuclear Medicine
CPT code 78610 denotes a diagnostic nuclear medicine study of cerebral perfusion using a gamma–emitting radioactive tracer to evaluate blood flow to the brain. This imaging procedure has national relevance for stroke evaluation, cerebrovascular disease assessment, and select neurologic diagnostic pathways where regional cerebral blood flow information informs clinical decisions. Payers commonly covering this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise clinical and billing overview of CPT code 78610, including the clinical context for use, typical sites of service, common modifiers, and payer coverage patterns. The publication summarizes benchmark considerations, payer policy themes, and coding nuances that affect claims submission and adjudication. It also outlines the clinical indications that most often prompt cerebral perfusion imaging and highlights areas where documentation and coding clarity are important for reimbursement and utilization oversight. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 78610 policy alerts
Get alerted when payer policies referencing 78610 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 78610 describes a diagnostic nuclear medicine procedure that assesses cerebral perfusion using a gamma–emitting radioactive tracer. The study measures how well blood flows to the brain, typically by injecting a radiotracer and obtaining scintigraphic or SPECT images to evaluate regional cerebral blood flow.
-
Service type: Diagnostic nuclear medicine study
-
Typical site of service: Hospital outpatient imaging center, radiology or nuclear medicine department, or specialized diagnostic imaging facility